Wize Pharma

Wize Pharma Long-term Debt

Delisted·Jan 10, 2019

Long-Term Debt of Wize Pharma (WIZP) as of Nov 19, 2026.

Long-term Debt

-USD

Last updated:

Long-Term Debt of Wize Pharma is 2026 - USD. Long-Term Debt of Wize Pharma was 2025 - USD. It decreases by % lower compared to the previous year.

The Wize Pharma Long-term Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Long-term Debt
Date
Long-term Debt
Jan 1, 2006
0.00 USD
Jan 1, 2007
0.00 USD
Jan 1, 2008
0.00 USD
Jan 1, 2009
0.00 USD
Jan 1, 2010
0.00 USD
Jan 1, 2011
0.00 USD
Jan 1, 2012
0.00 USD
Jan 1, 2013
0.00 USD
The Wize Pharma Long-term Debt history
YEARLong-term DebtYoY
0.00USD—
0.00USD—
0.00USD—
0.00USD—
0.00USD—
0.00USD—
0.00USD—
0.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Wize Pharma Stock analysis

What does Wize Pharma do? Wize Pharma Inc. is a leading biopharmaceutical company specializing in the development and marketing of innovative products for the treatment of eye diseases. The company was founded in 1997 and is headquartered in Herzliya Pituach, Israel. It focuses on the research, development, manufacturing, and marketing of eye disease treatments. The company aims to become a leading brand in the field of eye health and offers high-quality services in eye care. Wize Pharma Inc. operates different divisions, with its main divisions being the development and marketing of eye therapeutics, including LO2A and LO2B. LO2A is an innovative therapy for dry eye, while LO2B is an intraoperative formulation used in glaucoma surgery. The company's products provide effective and sustainable solutions for the treatment of eye diseases. Wize Pharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Wize Pharma stock

On Eulerpool you can find the complete historical development of Long-Term Debt Wize Pharma since 2006 – with annual values, charts, and detailed analysis.

Long-term debt represents obligations due after one year. It is a key component of a company's capital structure and leverage.

Long-Term Debt's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Long-Term Debt's Wize Pharma historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Wize Pharma

All Key Metrics — Wize Pharma